Table 5.
Comparison to results from other studies using IGRT for prostate cancer
| Study | Method | Acute toxicity GU by grade (%) |
Acute toxicity GI by grade (%) |
||||
|---|---|---|---|---|---|---|---|
| 2 | 3 | 4 | 2 | 3 | 4 | ||
| Present study (IGRT) (n = 249) |
96% conformal RT fiducials 78 Gy | 54 | 9 | 0 | 9 | 0 | 0 |
| Lips et al. (5) (n = 331) |
IMRT fiducials 76 Gy |
47 | 3 | 0 | 30 | 0 | 0 |
| Soete et al. (6) (n = 238) |
IG Arc therapy | 37 | 16 | 0 | 19 | 6 | 0 |
| Ghadjar et al. (7) (n = 39) |
IMRT fiducials 80 Gy | 56 | 8 | 0 | 3 | 0 | 0 |
| Cheng et al. (8) (n = 76) |
Tomotherapy 78.9 Gy |
38 | 0 | 0 | 25 | 0 | 0 |
| Martin et al. (9) (n = 259) |
87% conformal RT fiducials 79.8 Gy | 33 | 0 | 0 | 10 | 0 | 0 |